AAAAAA

   
Results: 1-25 | 26-38
Results: 1-25/38
PHASE I II TRIAL OF ALL-TRANS-RETINOIC ACID AND TAMOXIFEN IN PATIENTSWITH ADVANCED BREAST-CANCER/
Authors: BUDD GT ADAMSON PC GUPTA M HOMAYOUN P SANDSTROM SK MURPHY RF MCLAIN D TUASON L PEEREBOOM D BUKOWSKI RM GANAPATHI R
Citation: Gt. Budd et al., PHASE I II TRIAL OF ALL-TRANS-RETINOIC ACID AND TAMOXIFEN IN PATIENTSWITH ADVANCED BREAST-CANCER/, Clinical cancer research, 4(3), 1998, pp. 635-642
PHASE I II TRIAL OF ALL-TRANS-RETINOIC ACID AND TAMOXIFEN IN PATIENTSWITH ADVANCED BREAST-CANCER/
Authors: BUDD GT ADAMSON PC GUPTA M HOMAYOUN P SANDSTROM SK MURPHY RF MCLAIN D TUASON L PEEREBOOM D BUKOWSKI RM GANAPATHI R
Citation: Gt. Budd et al., PHASE I II TRIAL OF ALL-TRANS-RETINOIC ACID AND TAMOXIFEN IN PATIENTSWITH ADVANCED BREAST-CANCER/, Clinical cancer research, 4(3), 1998, pp. 635-642
SIGNAL-TRANSDUCTION ABNORMALITIES IN T-LYMPHOCYTES FROM PATIENTS WITHADVANCED RENAL-CARCINOMA - CLINICAL RELEVANCE AND EFFECTS OF CYTOKINETHERAPY
Authors: BUKOWSKI RM RAYMAN P UZZO R BLOOM T SANDSTROM K PEEREBOOM D OLENCKI T BUDD GT MCLAIN D ELSON P NOVICK A FINKE JH
Citation: Rm. Bukowski et al., SIGNAL-TRANSDUCTION ABNORMALITIES IN T-LYMPHOCYTES FROM PATIENTS WITHADVANCED RENAL-CARCINOMA - CLINICAL RELEVANCE AND EFFECTS OF CYTOKINETHERAPY, Clinical cancer research, 4(10), 1998, pp. 2337-2347
PHASE-I TRIAL OF CAPECITABINE AND SUBCUTANEOUS INTERFERON-ALPHA IN RENAL-CELL CARCINOMA (RCC)
Authors: BUKOWSKI RM OLENCKI T BOCOCK K BUDD GT PEEREBOOM D MCLAIN D GRIFFIN T
Citation: Rm. Bukowski et al., PHASE-I TRIAL OF CAPECITABINE AND SUBCUTANEOUS INTERFERON-ALPHA IN RENAL-CELL CARCINOMA (RCC), Annals of oncology, 9, 1998, pp. 458-458
CLINICAL PHARMACOKINETICS OF PERILLYL ALCOHOL (POH) AND METABOLITES FOLLOWING ORAL DOSING
Authors: CHAN KK ZHANG Z CHEN H GANAPATHI R HAYTON W ELSON P HAWK E KELLOFF G BUDD GT
Citation: Kk. Chan et al., CLINICAL PHARMACOKINETICS OF PERILLYL ALCOHOL (POH) AND METABOLITES FOLLOWING ORAL DOSING, Annals of oncology, 9, 1998, pp. 476-476
A MULTICENTER RANDOMIZED CLINICAL-TRIAL OF GOSERELIN VERSUS SURGICAL OVARIECTOMY IN PREMENOPAUSAL PATIENTS WITH RECEPTOR-POSITIVE METASTATIC BREAST-CANCER - AN INTERGROUP STUDY
Authors: TAYLOR CW GREEN S DALTON WS MARTINO S RECTOR D INGLE JN ROBERT NJ BUDD GT PARADELO JC NATALE RB BEARDEN JD MAILLIARD JA OSBORNE CK
Citation: Cw. Taylor et al., A MULTICENTER RANDOMIZED CLINICAL-TRIAL OF GOSERELIN VERSUS SURGICAL OVARIECTOMY IN PREMENOPAUSAL PATIENTS WITH RECEPTOR-POSITIVE METASTATIC BREAST-CANCER - AN INTERGROUP STUDY, Journal of clinical oncology, 16(3), 1998, pp. 994-999
EFFECT OF SULINDAC SULFONE ON PROLIFERATION, APOPTOSIS, AND POLYPS INA CLINICAL-TRIAL IN FAMILIAL ADENOMATOUS POLYPOSIS (FAP) WITH RECTAL POLYPS
Authors: VANSTOLK R BUDD GT KRESTY R GANAPATHI R ELSON P CHURCH J PIAZZA G FRYER B PROVENCHER K PAMUKCU R HAWK E KELLOFF G STONER G
Citation: R. Vanstolk et al., EFFECT OF SULINDAC SULFONE ON PROLIFERATION, APOPTOSIS, AND POLYPS INA CLINICAL-TRIAL IN FAMILIAL ADENOMATOUS POLYPOSIS (FAP) WITH RECTAL POLYPS, Gastroenterology, 114(4), 1998, pp. 2881-2881
PHASE-II TRIAL OF INTERLEUKIN-2 AND INTERFERON-ALPHA IN PATIENTS WITHRENAL-CELL CARCINOMA - CLINICAL-RESULTS AND IMMUNOLOGICAL CORRELATES OF RESPONSE
Authors: BUKOWSKI RM OLENCKI T WANG Q PEEREBOOM D BUDD GT ELSON P SANDSTROM K TUASON L RAYMAN P TUBBS R MCLAIN D KLEIN E NOVICK A FINKE J
Citation: Rm. Bukowski et al., PHASE-II TRIAL OF INTERLEUKIN-2 AND INTERFERON-ALPHA IN PATIENTS WITHRENAL-CELL CARCINOMA - CLINICAL-RESULTS AND IMMUNOLOGICAL CORRELATES OF RESPONSE, Journal of immunotherapy with emphasis on tumor immunology, 20(4), 1997, pp. 301-311
MEGESTROL-ACETATE AND AMINOGLUTETHIMIDE HYDROCORTISONE IN SEQUENCE ORIN COMBINATION AS 2ND-LINE ENDOCRINE THERAPY OF ESTROGEN RECEPTOR-POSITIVE METASTATIC BREAST-CANCER - A SOUTHWEST-ONCOLOGY-GROUP PHASE-III TRIAL/
Authors: RUSSELL CA GREEN SJ OSULLIVAN J HYNES HE BUDD GT CONGDON JE MARTINO S OSBORNE CK
Citation: Ca. Russell et al., MEGESTROL-ACETATE AND AMINOGLUTETHIMIDE HYDROCORTISONE IN SEQUENCE ORIN COMBINATION AS 2ND-LINE ENDOCRINE THERAPY OF ESTROGEN RECEPTOR-POSITIVE METASTATIC BREAST-CANCER - A SOUTHWEST-ONCOLOGY-GROUP PHASE-III TRIAL/, Journal of clinical oncology, 15(7), 1997, pp. 2494-2501
SELECTIVE APOPTOSIS OF NEOPLASTIC-CELLS ACCOMPANIES POLYP REGRESSION IN FAMILIAL ADENOMATOUS POLYPOSIS (FAP) PATIENTS TREATED WITH FGN-1 (SULINDAC SULFONE) - EVIDENCE FOR A CYCLOOXYGENASE INDEPENDENT MECHANISM
Authors: PIAZZA GA FRYER BH VANSTOLK RU BUDD GT STONER GD HAWK E KELLOFF G PAMUKCU R AHNEN DJ GANAPATHI R
Citation: Ga. Piazza et al., SELECTIVE APOPTOSIS OF NEOPLASTIC-CELLS ACCOMPANIES POLYP REGRESSION IN FAMILIAL ADENOMATOUS POLYPOSIS (FAP) PATIENTS TREATED WITH FGN-1 (SULINDAC SULFONE) - EVIDENCE FOR A CYCLOOXYGENASE INDEPENDENT MECHANISM, Gastroenterology, 112(4), 1997, pp. 638-638
PHASE-I TRIAL OF SULINDAC SULFONE IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS (FAP) WITH RECTAL POLYPS - OPTIMAL DOSE AND SAFETY
Authors: VANSTOLK RU BUDD GT HAYTON W ELSON P PROVENCHER K CHURCH JM GANAPATHI R STONER G HAWK E PAMUKCU R KELLOFF G CHAN K
Citation: Ru. Vanstolk et al., PHASE-I TRIAL OF SULINDAC SULFONE IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS (FAP) WITH RECTAL POLYPS - OPTIMAL DOSE AND SAFETY, Gastroenterology, 112(4), 1997, pp. 673-673
CLINICOPATHOLOGICAL CORRELATION OF RECTAL ADENOMA REGRESSION IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS (FAP) TREATED WITH SULINDAC SULFONE IN A PHASE I II TRIAL/
Authors: VANSTOLK RU DEYOUNG B CHURCH JM GANAPATHI R PROVENCHER K STONER G HAWK E PAMUKCU R KELLOFF G BUDD GT
Citation: Ru. Vanstolk et al., CLINICOPATHOLOGICAL CORRELATION OF RECTAL ADENOMA REGRESSION IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS (FAP) TREATED WITH SULINDAC SULFONE IN A PHASE I II TRIAL/, Gastroenterology, 112(4), 1997, pp. 673-673
RANDOMIZED TRIAL OF CARBOPLATIN PLUS AMIFOSTINE VERSUS CARBOPLATIN ALONE IN PATIENTS WITH ADVANCED SOLID TUMORS
Authors: BUDD GT GANAPATHI R ADELSTEIN DJ PELLEY R OLENCKI T PETRUS J MCLAIN D ZHANG JL CAPIZZI R BUKOWSKI RM
Citation: Gt. Budd et al., RANDOMIZED TRIAL OF CARBOPLATIN PLUS AMIFOSTINE VERSUS CARBOPLATIN ALONE IN PATIENTS WITH ADVANCED SOLID TUMORS, Cancer, 80(6), 1997, pp. 1134-1140
PELVIC COMPUTED-TOMOGRAPHY OF BREAST-CARCINOMA PATIENTS - SHOULD IT ROUTINELY BE ADDED TO ABDOMINAL COMPUTED-TOMOGRAPHY
Authors: MEYER JI HERTS BR EINSTEIN DM SINGER AA BUDD GT COHEN MAH
Citation: Ji. Meyer et al., PELVIC COMPUTED-TOMOGRAPHY OF BREAST-CARCINOMA PATIENTS - SHOULD IT ROUTINELY BE ADDED TO ABDOMINAL COMPUTED-TOMOGRAPHY, Cancer, 79(3), 1997, pp. 500-504
PHASE-I TRIAL OF SUBCUTANEOUS INTERLEUKIN-3 IN PATIENTS WITH REFRACTORY MALIGNANCY - HEMATOLOGICAL, IMMUNOLOGICAL, AND PHARMACODYNAMIC FINDINGS
Authors: BUKOWSKI RM OLENCKI T GUNN H MCLAIN D BUDD GT SANDSTROM K TUASON L REDOVAN C RAYMAN P TUBBS R RESTA D ELSON P FINKE J
Citation: Rm. Bukowski et al., PHASE-I TRIAL OF SUBCUTANEOUS INTERLEUKIN-3 IN PATIENTS WITH REFRACTORY MALIGNANCY - HEMATOLOGICAL, IMMUNOLOGICAL, AND PHARMACODYNAMIC FINDINGS, Clinical cancer research, 2(2), 1996, pp. 347-357
IMMUNOMODULATORY EFFECTS OF INTERLEUKIN-2 AND INTERLEUKIN-4 IN PATIENTS WITH MALIGNANCY
Authors: OLENCKI T FINKE J TUBBS R TUASON L GREENE T MCLAIN D SWANSON SJ HERZOG P STANLEY T EDINGER M BUDD GT BUKOWSKI RM
Citation: T. Olencki et al., IMMUNOMODULATORY EFFECTS OF INTERLEUKIN-2 AND INTERLEUKIN-4 IN PATIENTS WITH MALIGNANCY, Journal of immunotherapy with emphasis on tumor immunology, 19(1), 1996, pp. 69-80
CLINICAL EFFECTS OF AMIFOSTINE (ETHYOL(R)) IN PATIENTS TREATED WITH CARBOPLATIN
Authors: BUDD GT GANAPATHI R BUKOWSKI RM MURTHY S
Citation: Gt. Budd et al., CLINICAL EFFECTS OF AMIFOSTINE (ETHYOL(R)) IN PATIENTS TREATED WITH CARBOPLATIN, European journal of cancer, 32A, 1996, pp. 43-45
AMIFOSTINE AND CHEMOTHERAPY-RELATED THROMBOCYTOPENIA
Authors: BUDD GT
Citation: Gt. Budd, AMIFOSTINE AND CHEMOTHERAPY-RELATED THROMBOCYTOPENIA, Seminars in oncology, 23(4), 1996, pp. 49-52
IFOSFAMIDE IN THE TREATMENT OF SOFT-TISSUE SARCOMAS
Authors: CONNELLY EF BUDD GT
Citation: Ef. Connelly et Gt. Budd, IFOSFAMIDE IN THE TREATMENT OF SOFT-TISSUE SARCOMAS, Seminars in oncology, 23(3), 1996, pp. 16-21
PHASE-II TRIAL OF SUBCUTANEOUSLY ADMINISTERED GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
Authors: WOS E OLENCKI T TUASON L BUDD GT PEEREBOOM D SANDSTROM K MCLAIN D FINKE J BUKOWSKI RM
Citation: E. Wos et al., PHASE-II TRIAL OF SUBCUTANEOUSLY ADMINISTERED GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA, Cancer, 77(6), 1996, pp. 1149-1153
RANDOMIZED TRIAL OF MAID (MESNA, ADRIAMYCIN, IFOSFAMIDE, DECARBAZINE)CHEMOTHERAPY WITH G-CSF ALONE OR WITH G-CSF PLUS VARYING DOSES OF INTERLEUKIN-6 (IL-6)
Authors: BUDD GT SAMUELS B GOCKERMAN J BAKER L MARGOLIN K ZALUPSKI M FELSER J JOHNSON B ISAACS R BUKOWSKI RM
Citation: Gt. Budd et al., RANDOMIZED TRIAL OF MAID (MESNA, ADRIAMYCIN, IFOSFAMIDE, DECARBAZINE)CHEMOTHERAPY WITH G-CSF ALONE OR WITH G-CSF PLUS VARYING DOSES OF INTERLEUKIN-6 (IL-6), Blood, 88(10), 1996, pp. 3281-3281
INDUCTION OF THE CXC CHEMOKINES IP-10 AND MIG IN PATIENTS (PTS) RECEIVING RHUIL-12 OR RIL-2
Authors: BUKOWSKI RM DON W REDOVAN C MCLAIN D SANDSTROM K OLENCKI T BUDD GT PEEREBOOM D GRIFFIN T TANNENBAUM C FINKE JK
Citation: Rm. Bukowski et al., INDUCTION OF THE CXC CHEMOKINES IP-10 AND MIG IN PATIENTS (PTS) RECEIVING RHUIL-12 OR RIL-2, Blood, 88(10), 1996, pp. 1247-1247
SHORT-COURSE FAC-M VERSUS 1 YEAR OF CMFVP IN NODE-POSITIVE, HORMONE RECEPTOR-NEGATIVE BREAST-CANCER - AN INTERGROUP STUDY
Authors: BUDD GT GREEN S OBRYAN RM MARTINO S ABELOFF MD RINEHART JJ HAHN R HARRIS J TORMEY D OSULLIVAN J OSBORNE CK
Citation: Gt. Budd et al., SHORT-COURSE FAC-M VERSUS 1 YEAR OF CMFVP IN NODE-POSITIVE, HORMONE RECEPTOR-NEGATIVE BREAST-CANCER - AN INTERGROUP STUDY, Journal of clinical oncology, 13(4), 1995, pp. 831-839
PALLIATIVE CHEMOTHERAPY OF ADULT SOFT-TISSUE SARCOMAS
Authors: BUDD GT
Citation: Gt. Budd, PALLIATIVE CHEMOTHERAPY OF ADULT SOFT-TISSUE SARCOMAS, Seminars in oncology, 22(2), 1995, pp. 30-34
ACCELERATED INDUCTION THERAPY AND RESECTION FOR POOR-PROGNOSIS STAGE-III NON-SMALL-CELL LUNG-CANCER
Authors: RICE TW ADELSTEIN DJ KOKA A TEFFT M KIRBY TJ VANKIRK MA TAYLOR ME OLENCKI TE PEEREBOOM D BUDD GT
Citation: Tw. Rice et al., ACCELERATED INDUCTION THERAPY AND RESECTION FOR POOR-PROGNOSIS STAGE-III NON-SMALL-CELL LUNG-CANCER, The Annals of thoracic surgery, 60(3), 1995, pp. 586-592
Risultati: 1-25 | 26-38